Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications
Introduction: There are increasing concerns world-wide with growing rates of antibiotic resistance necessitating urgent action. There have been a number of initiatives in the Republic of Srpska in recent years to address this and improve rational antibiotic prescribing and dispensing despite limited...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2018.00442/full |
id |
doaj-55bf5d466d254d14b16f69e4d1ef1c96 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ljubica Bojanić Ljubica Bojanić Vanda Marković-Peković Vanda Marković-Peković Ranko Škrbić Nataša Stojaković Mirjana Ðermanović Mirjana Ðermanović Janja Bojanić Janja Bojanić Jurij Fürst Amanj B. Kurdi Amanj B. Kurdi Brian Godman Brian Godman Brian Godman Brian Godman |
spellingShingle |
Ljubica Bojanić Ljubica Bojanić Vanda Marković-Peković Vanda Marković-Peković Ranko Škrbić Nataša Stojaković Mirjana Ðermanović Mirjana Ðermanović Janja Bojanić Janja Bojanić Jurij Fürst Amanj B. Kurdi Amanj B. Kurdi Brian Godman Brian Godman Brian Godman Brian Godman Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications Frontiers in Pharmacology antibiotic utilization antibiotic resistance cross national comparative study initiatives Republic of Srpska quality indicators |
author_facet |
Ljubica Bojanić Ljubica Bojanić Vanda Marković-Peković Vanda Marković-Peković Ranko Škrbić Nataša Stojaković Mirjana Ðermanović Mirjana Ðermanović Janja Bojanić Janja Bojanić Jurij Fürst Amanj B. Kurdi Amanj B. Kurdi Brian Godman Brian Godman Brian Godman Brian Godman |
author_sort |
Ljubica Bojanić |
title |
Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications |
title_short |
Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications |
title_full |
Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications |
title_fullStr |
Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications |
title_full_unstemmed |
Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications |
title_sort |
recent initiatives in the republic of srpska to enhance appropriate use of antibiotics in ambulatory care; their influence and implications |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2018-05-01 |
description |
Introduction: There are increasing concerns world-wide with growing rates of antibiotic resistance necessitating urgent action. There have been a number of initiatives in the Republic of Srpska in recent years to address this and improve rational antibiotic prescribing and dispensing despite limited resources to fund multiple initiatives.Objective: Analyse antibiotic utilization patterns in the Republic of Srpska following these multiple initiatives as a basis for developing future programmes in the Republic if needed.Methods: Observational retrospective study of total outpatient antibiotic utilization from 2010 to 2015, based on data obtained from the Public Health Institute, alongside documentation of ongoing initiatives to influence utilization. The quality of antibiotic utilization principally assessed according to ESAC, ECDC, and WHO quality indicators and DU 90% (the drug utilization 90%) profile as well as vs. neighboring countries.Results: Following multiple initiatives, antibiotic utilization remained relatively stable in the Republic at 15.6 to 18.4 DIDs, with a decreasing trend in recent years, with rates comparable or lower than neighboring countries. Amoxicillin and the penicillins accounted for 29–40 and 50% of total utilization, respectively. Overall, limited utilization of co-amoxiclav (7–11%), cephalosporins, macrolides, and quinolones, as well as low use of third and fourth generation cephalosporins vs. first and second cephalosporins. However, increasing utilization of co-amoxiclav and azithromycin, as well as higher rates of quinolone utilization compared to some countries, was seen.Conclusions: Multiple interventions in the Republic of Srpska in recent years have resulted in one of the lowest utilization of antibiotics when compared with similar countries, acting as an exemplar to others. However, there are some concerns with current utilization of co-amoxiclav and azithromycin which are being addressed. This will be the subject of future research activities. |
topic |
antibiotic utilization antibiotic resistance cross national comparative study initiatives Republic of Srpska quality indicators |
url |
https://www.frontiersin.org/article/10.3389/fphar.2018.00442/full |
work_keys_str_mv |
AT ljubicabojanic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT ljubicabojanic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT vandamarkovicpekovic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT vandamarkovicpekovic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT rankoskrbic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT natasastojakovic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT mirjanaðermanovic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT mirjanaðermanovic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT janjabojanic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT janjabojanic recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT jurijfurst recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT amanjbkurdi recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT amanjbkurdi recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT briangodman recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT briangodman recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT briangodman recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications AT briangodman recentinitiativesintherepublicofsrpskatoenhanceappropriateuseofantibioticsinambulatorycaretheirinfluenceandimplications |
_version_ |
1725943787156406272 |
spelling |
doaj-55bf5d466d254d14b16f69e4d1ef1c962020-11-24T21:35:49ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122018-05-01910.3389/fphar.2018.00442372014Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and ImplicationsLjubica Bojanić0Ljubica Bojanić1Vanda Marković-Peković2Vanda Marković-Peković3Ranko Škrbić4Nataša Stojaković5Mirjana Ðermanović6Mirjana Ðermanović7Janja Bojanić8Janja Bojanić9Jurij Fürst10Amanj B. Kurdi11Amanj B. Kurdi12Brian Godman13Brian Godman14Brian Godman15Brian Godman16Public Health Institute, Banja Luka, Bosnia and HerzegovinaDepartment of Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and HerzegovinaMinistry of Health and Social Welfare, Banja Luka, Bosnia and HerzegovinaDepartment of Social Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and HerzegovinaDepartment of Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and HerzegovinaDepartment of Clinical Pharmacology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and HerzegovinaPublic Health Institute, Banja Luka, Bosnia and HerzegovinaDepartment of Pharmacy, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and HerzegovinaPublic Health Institute, Banja Luka, Bosnia and HerzegovinaDepartment of Epidemiology, Faculty of Medicine, University of Banja Luka, Banja Luka, Bosnia and HerzegovinaHealth Insurance Institute of Slovenia, Ljubljana, SloveniaStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United KingdomDepartment of pharmacology and toxicology, College of Pharmacy, Hawler Medical University, Erbil, IraqStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow, United Kingdom0Liverpool Health Economics Centre, Liverpool University, Liverpool, United Kingdom1Division of Clinical Pharmacology, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden2School of Pharmaceutical Sciences, Universiti Sains Malaysia, Kota Bharu, MalaysiaIntroduction: There are increasing concerns world-wide with growing rates of antibiotic resistance necessitating urgent action. There have been a number of initiatives in the Republic of Srpska in recent years to address this and improve rational antibiotic prescribing and dispensing despite limited resources to fund multiple initiatives.Objective: Analyse antibiotic utilization patterns in the Republic of Srpska following these multiple initiatives as a basis for developing future programmes in the Republic if needed.Methods: Observational retrospective study of total outpatient antibiotic utilization from 2010 to 2015, based on data obtained from the Public Health Institute, alongside documentation of ongoing initiatives to influence utilization. The quality of antibiotic utilization principally assessed according to ESAC, ECDC, and WHO quality indicators and DU 90% (the drug utilization 90%) profile as well as vs. neighboring countries.Results: Following multiple initiatives, antibiotic utilization remained relatively stable in the Republic at 15.6 to 18.4 DIDs, with a decreasing trend in recent years, with rates comparable or lower than neighboring countries. Amoxicillin and the penicillins accounted for 29–40 and 50% of total utilization, respectively. Overall, limited utilization of co-amoxiclav (7–11%), cephalosporins, macrolides, and quinolones, as well as low use of third and fourth generation cephalosporins vs. first and second cephalosporins. However, increasing utilization of co-amoxiclav and azithromycin, as well as higher rates of quinolone utilization compared to some countries, was seen.Conclusions: Multiple interventions in the Republic of Srpska in recent years have resulted in one of the lowest utilization of antibiotics when compared with similar countries, acting as an exemplar to others. However, there are some concerns with current utilization of co-amoxiclav and azithromycin which are being addressed. This will be the subject of future research activities.https://www.frontiersin.org/article/10.3389/fphar.2018.00442/fullantibiotic utilizationantibiotic resistancecross national comparative studyinitiativesRepublic of Srpskaquality indicators |